doi: 10.1093/nutrit/nuaa067 366
Kobayashi K, Toyoda M, Tone A, et al
Patients should understand the potential downsides before starting treatment
The findings of a large US real-world cohort (n= 18,000) study, published in 2024, show that patients on tirzepatide were significantly more likely to achieve 5 %, 10 % and 15 % weight loss compared with semaglutide (HR 1.76, 2.54, 3.24, respectively), with a 12-month mean weight difference of -6.9% 8
Check the packaging or the syringe barrel printing
Experimental studies explore how the compound behaves in environments replicating gastric acidity, mucosal damage, and chemically induced erosion